<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>52</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">MiR-934 Exacerbates Malignancy of Gastric Cancer Cells by Targeting ZFP36</title>
    <FirstPage>1720</FirstPage>
    <LastPage>1729</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zhicheng</FirstName>
        <LastName>Pan</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Huazhong</FirstName>
        <LastName>Yun</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Yun</FirstName>
        <LastName>Xiao</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Fei</FirstName>
        <LastName>Tong</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Guodong</FirstName>
        <LastName>Liu</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ge</FirstName>
        <LastName>Zhang</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
      <Author>
        <FirstName>Jianbo</FirstName>
        <LastName>Han</LastName>
        <affiliation locale="en_US">General Surgery Department, Nanjing Red Cross Hospital, Nanjing City, Jiangsu Province, 210000, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>01</Month>
        <Day>26</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>04</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: In order to explore new targets for the treatment of gastric cancer (GC), we investigated the regulatory mechanism of miR-934 in the malignant phenotype of gastric cancer.
&#xD;

Results: GC tissues and cell lines showed notably higher levels of miR-934. Overexpression of miR-934 promoted cell viability, migration and invasion, while inhibited cell apoptosis of GC cells. ZFP36 was predicted and verified to be the target of miR-934 and low protein levels of ZFP36 were observed in GC tissues. The ZFP36 protein expressions were suppressed by miR-934 overexpression, while were facilitated by miR-934 inhibition. Furthermore, the carcinogenic functions of miR-934 were partially reversed after ZFP36 overexpression. The results of in vivo experiments further demonstrated that miR-934 promoted tumor growth and repressed the protein expression of ZFP36.
&#xD;

Conclusion: miR-934 served as a tumor promoter in GC via targeting ZFP36, and ZFP36 overexpression could efficiently relieve malignant phenotypes caused by miR-934, which prompted an exploitable molecular target for GC treatment.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/30977</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/30977/8015</pdf_url>
  </Article>
</Articles>
